Vanguard Group Inc Brainstorm Cell Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,510,640 shares of BCLI stock, worth $2.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,510,640
Previous 1,510,640
-0.0%
Holding current value
$2.34 Million
Previous $513,000
32.36%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BCLI
# of Institutions
41Shares Held
10.8MCall Options Held
160KPut Options Held
30.5K-
Armistice Capital, LLC New York, NY6.9MShares$10.7 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA683KShares$1.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY386KShares$598,9410.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA340KShares$527,2320.01% of portfolio
-
Weaver Consulting Group234KShares$363,2510.02% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $56.6M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...